Author | Lisa B. Samalonis


Pediatric dermatoses: Off-label biologic use carries risks, benefits

April 01, 2010

Psoriasis in adults is among the most-researched inflammatory skin diseases. Yet treatment options for moderate-to-severe atopic dermatitis and psoriasis in children represents a largely unmet medical need, according to an expert.

Topical retinoid treatments effective for brown spots, fine wrinkles

January 01, 2010

Topical retinoid treatment yields gradual results, but the modality can be effective for some wrinkles and depigmentation.

On the horizon: Gene therapy, stem cell therapy studied for the treatment of chronic wounds

December 01, 2009

Gene and stem cell research is showing promise for the treatment of chronic wounds

Just say 'no': Drug interactions must be evaluated before dermatologic procedures

November 01, 2009

Elderly patients take numerous medications, requiring careful consideration before treatment.

The root of the problem: Blood work-up, scalp biopsy provide important clues to hair loss origins

October 01, 2009

Hair loss can be caused by various factors, including genetics and stress. Doctors must determine the cause in order to treat the condition effectively.

Baby talk: Neonatal pigmentary skin lesions: Some require long-term follow-up

September 01, 2009

Neonatal pigmentary conditions are common; however, some serious conditions should be evaluated and followed by a pediatric dermatologist throughout the child's life, an expert says.

Marginally better: Larger margins should be new standard of care for melanoma excision

August 06, 2009

Surgical margins for standard excision should include 9 mm of normal-appearing skin for melanoma in situs, according to a recent study.

Woundcare systems: Integrated approach provides uniform evidenced-based care

December 01, 2008

An integrated approach to woundcare yields improved outcomes for patients, according to recent research. Over the past five years, numerous organizations have come up with guidelines for integrated woundcare systems, an expert says.

Understanding the benefits of p16 testing for high-risk familial melanoma patients

January 01, 2008

P16-mutation carriers are at extremely high risk for developing melanoma. Many high-risk melanoma clinics worldwide are reporting genetic test results, and clinical testing also is increasing in the United States. There are currently no guidelines regulating genetic testing in the United States, but melanoma genetics experts are working to develop meaningful guidelines that will, hopefully, be published in early 2008.

Steps to managing stress

April 01, 2007

In addition to learning to say 'no' to extra commitments, Dr. Woodall also recommends exercising routinely, eating right and not indulging in drugs, alcohol and other unhealthy habits.